The Oncology Institute, Inc.TOINASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank42
3Y CAGR-26.4%
5Y CAGR+1.7%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-26.4%/yr
Quarterly compound
5Y CAGR
+1.7%/yr
Recent deceleration
Percentile
P42
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.95% |
| Q3 2025 | 13.99% |
| Q2 2025 | 14.75% |
| Q1 2025 | 4.13% |
| Q4 2024 | 0.37% |
| Q3 2024 | 1.34% |
| Q2 2024 | 4.13% |
| Q1 2024 | 10.35% |
| Q4 2023 | 4.57% |
| Q3 2023 | 2.26% |
| Q2 2023 | 5.29% |
| Q1 2023 | 6.68% |
| Q4 2022 | 9.92% |
| Q3 2022 | 6.66% |
| Q2 2022 | 10.44% |
| Q1 2022 | 5.46% |
| Q4 2021 | 0.06% |
| Q3 2021 | 4.88% |
| Q2 2021 | 2.60% |
| Q1 2021 | -0.79% |
| Q4 2020 | 3.63% |
| Q3 2020 | -0.06% |
| Q2 2020 | 7.40% |
| Q1 2020 | 0.00% |
| Q4 2018 | 0.00% |